The Hong Kong Association of The Pharmaceutical Industry (HKAPI) held its Annual General Meeting on 2 April 2020 and delighted to announce the formation of the New Board (2020 – 2022) with following members:

President
Dr Daniel THURLEY
總經理
羅氏大藥廠香港有限公司

Vice President
Ms. Dorine LEUNG
General Manager & Country Vice President
Novartis Pharmaceuticals (HK) Ltd.

Board of Directors (by alphabetical order of their surname)
Ms Kara CHEUNG
General Manager, Hong Kong & Macau
Amgen Hong Kong Limited

Mr FONG Wai-ting
Head of Country Management & Vice President, Healthcare
Medinova AG

Ms Peggy FUNG
General Manager, Pharmaceuticals – Hong Kong & Macau
GlaxoSmithKline Ltd.

Mr Alex HO
總經理
Janssen, Johnson & Johnson (HK) Limited

Mr Gwenaël MENEUX
General Manager, Hong Kong & Macau
AstraZeneca Hong Kong Limited

Mr Richard SUN
General Manager, HK, Malaysia & Singapore
AbbVie Limited

Mr Lawrence WONG
General Manager, Hong Kong
Ferring Pharmaceuticals Limited

While congratulating the new Board members on board, we also thank those Board members served in 2018 -2020 for their remarkable leadership, time and effort for serving the industry.

In addition, we shall thank for all taskforce leads and taskforce members for their valuable contribution and passion to work for the strategic initiatives and for the system betterment in the past two years.

With those collective wisdom and effort, the HKAPI is able to continue bringing visible achievements in driving expedient access to innovative healthcare solutions for the people of Hong Kong and Macao with high ethical standard.